Search

everythinglearnresearchcommunity

for

Search:↓

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

CT scans can find serious prostate cancer even when PSA levels are low.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Cancer prevention is crucial, with a focus on research and improved screening methods.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

Finasteride is safe for long-term use in prostate cancer treatment.

Finasteride reduces prostate cancer risk but may increase high-grade cancer risk.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.